EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.
about
Lung cancer in the Indian subcontinentLung cancer: prevalent trends & emerging conceptsDrug-sensitive FGFR3 mutations in lung adenocarcinoma.Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer.Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cellsFrequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patientsEvaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study.Optimizing the management of lung cancer: Role of the pulmonologist in India.EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center.Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients.A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological study.Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma.
P2860
Q28075788-E44986AC-438C-4C74-AB8B-8CC56EEAE046Q28392286-A503C2AE-9C86-408F-B65B-F14B9D0A5EC3Q33564782-08E71DBD-618F-4137-84EC-725E00F0154AQ34658204-BC3DD855-135D-43FC-9EDB-1C1FEA3DC1E3Q34892066-57EBEEFD-B82B-4A44-A531-1EADB87CA065Q35016912-A78D7902-8BD0-4C95-BCCB-B4C57152FBEBQ36330709-06AD80F7-43B1-4C07-AEBA-639D86EA4EA2Q36966128-13DD2739-ADEC-42A0-A6A5-1EF7952B2AF6Q37177217-AF45E386-2224-4175-A4B2-BCCF6458CC86Q37735770-6306D141-9BD6-4C33-8367-0DB9C85A7ABCQ40060953-A51EBF27-1F4C-43A0-A0AA-1FE744641D4AQ44070495-D6950447-B1B2-4568-91BC-F53BBFF2D155Q44669701-59DDE8B1-8AAB-45F1-8A74-9B9BFE411258Q54114458-E8472810-C637-436F-B3AD-C3592508EEE1Q54990179-633A2831-3D86-43EF-A058-47A4DE6B13C9
P2860
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@ast
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@en
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@nl
type
label
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@ast
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@en
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@nl
prefLabel
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@ast
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@en
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@nl
P2093
P2860
P1433
P1476
EGFR mutations in Indian lung ...... come to EGFR targeted therapy.
@en
P2093
Abhishek Thavamani
Amit Joshi
Anuradha Chougule
Kumar Prabhash
Nilendu Purandare
Nirmala Jambekar
Rashmi Sharma
Rita Mulherkar
Saral Desai
Vanita Noronha
P2860
P304
P356
10.1371/JOURNAL.PONE.0061561
P407
P50
P577
2013-04-19T00:00:00Z